Turpault S - Search Results

Year	Number of Results
2009	1
2011	1
2013	1
2014	1
2016	2
2017	2
2019	2
2020	4
2021	2
2024	0

1

S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults.

Tran L, Nikanjam M, Capparelli EV, Bertino JS Jr, Nafziger AN, Kashuba ADM, Turpault S, Ma JD. Tran L, et al. Among authors: turpault s. Eur J Clin Pharmacol. 2021 Sep;77(9):1349-1356. doi: 10.1007/s00228-021-03123-y. Epub 2021 Mar 23. Eur J Clin Pharmacol. 2021. PMID: 33754183

2

S-Warfarin Limited Sampling Models to Estimate Area Under the Concentration Versus Time Curve for Cytochrome P450 2C9 Baseline Activity and After Induction.

Chang AT, Bertino JS Jr, Nafziger AN, Kashuba AD, Turpault S, Lewis LD, Ma JD. Chang AT, et al. Among authors: turpault s. Ther Drug Monit. 2016 Jun;38(3):383-7. doi: 10.1097/FTD.0000000000000277. Ther Drug Monit. 2016. PMID: 26818625

3

Carbon-13 synthesis and NMR spectroscopic geometric isomer evaluation to support the filing of teriflunomide.

Kurz M, Gretzke D, Hörlein R, Turpault S, Atzrodt J, Derdau V. Kurz M, et al. Among authors: turpault s. J Labelled Comp Radiopharm. 2021 Feb;64(2):82-88. doi: 10.1002/jlcr.3876. Epub 2020 Aug 31. J Labelled Comp Radiopharm. 2021. PMID: 32840004

4

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants.

Lunven C, Guo Z, Turpault S, Delfolie A, Fauchoux N, Turner T, Baldinetti F. Lunven C, et al. Among authors: turpault s. J Clin Pharmacol. 2017 Jun;57(6):747-750. doi: 10.1002/jcph.854. Epub 2017 Jan 25. J Clin Pharmacol. 2017. PMID: 28120422 Free PMC article. Clinical Trial. No abstract available.

5

Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.

Hassani Z, Saleh A, Turpault S, Khiati S, Morelle W, Vignon J, Hugnot JP, Uro-Coste E, Legrand P, Delaforge M, Loiseau S, Clarion L, Lecouvey M, Volle JN, Virieux D, Pirat JL, Duffau H, Bakalara N. Hassani Z, et al. Among authors: turpault s. Mol Cancer Res. 2017 Oct;15(10):1376-1387. doi: 10.1158/1541-7786.MCR-17-0120. Epub 2017 Jun 20. Mol Cancer Res. 2017. PMID: 28634226

6

Impact of hepatic and renal impairment on the pharmacokinetics and tolerability of eliglustat therapy for Gaucher disease type 1.

Li J, Chen J, Kanamaluru V, Gaemers SJM, Peterschmitt MJ, Hou AW, Xue Y, Turpault S, Rudin D. Li J, et al. Among authors: turpault s. Mol Genet Metab. 2020 Feb;129(2):117-124. doi: 10.1016/j.ymgme.2019.11.002. Epub 2019 Nov 14. Mol Genet Metab. 2020. PMID: 31924461 Free article. Clinical Trial.

7

Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents.

Thibault N, Ibrahim J, Peterschmitt MJ, Puga AC, Ross L, Vu L, Xue Y, Turpault S. Thibault N, et al. Among authors: turpault s. Mol Genet Metab. 2020 Apr;129(4):278-285. doi: 10.1016/j.ymgme.2020.01.001. Epub 2020 Jan 7. Mol Genet Metab. 2020. PMID: 32029355 Free article. Clinical Trial.

8

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group. O'Connor P, et al. N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656. N Engl J Med. 2011. PMID: 21991951 Free article. Clinical Trial.

9

Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1.

Vu L, Cox GF, Ibrahim J, Peterschmitt MJ, Ross L, Thibault N, Turpault S. Vu L, et al. Among authors: turpault s. Mol Genet Metab Rep. 2020 Jan 21;22:100552. doi: 10.1016/j.ymgmr.2019.100552. eCollection 2020 Mar. Mol Genet Metab Rep. 2020. PMID: 31993325 Free PMC article.

10

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.

Filali-Ansary A, Lunven C, Turpault S, Beyer YJ, OʼBrien A, Delfolie A, Boyanova N, Sanderink GJ, Baldinetti F. Filali-Ansary A, et al. Among authors: turpault s. Ther Drug Monit. 2016 Aug;38(4):471-82. doi: 10.1097/FTD.0000000000000302. Ther Drug Monit. 2016. PMID: 27015245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year